Sign up Australia
Proactive Investors - Run By Investors For Investors
52-week High/Low: $2.97 / $1.95
Sector: Pharma & Biotech
Market Cap: $310.78M
22nd Century Group Inc (NYSE:XXII)

22nd Century Group Inc

22nd Century is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding.

The company’s primary mission in tobacco is to reduce the harm caused by smoking. The Company’s primary mission in hemp/cannabis is to...

22nd Century Group Inc

Interactive graph

col 3
col 4
col 5
col 6

22nd Century Group Inc Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use